We describes progress in system therapy for advanced papillary RCC. Opportunities and challenges around personalised therapy are discussed

Episode 264: Prostatectomy vs RT vs surveillance- the PROTECT trial

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London